Rapid Screening of Anticoagulation Compounds for Biological Target-Associated Adverse Effects Using a Deep-Learning Framework in the Management of Atrial Fibrillation

<b>Background:</b> Deep learning methods may be useful for drug compound interaction and discovery analysis. However, there has been limited research on their use for screening biologically related adverse effects. <b>Objectives:</b> This study aims to pre-emptively screen for likely drug use persis...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Tim Dong, Rhys Llewellyn, Melanie Hezzell, Gianni D. Angelini
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	MDPI AG 2025-09-01
Ráidu:	Bioengineering
Fáttát:	deep learning clinical trials adverse-effects screening drug discovery proteomics thrombotic disease prevention
Liŋkkat:	https://www.mdpi.com/2306-5354/12/9/972
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!